Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase

Journal of the Neurological Sciences

Volumn 175, Issue 1, 2000, Pages 40-44

  Mitoma, H ^a   Song, S Y ^b   Ishida, K ^c   Yamakuni, T ^b   Kobayashi, T ^c   Mizusawa, H ^c  

^a Mitoma Neurological Clinic   (Japan)

^b MITSUBISHI KASEI INST OF LIFE SCI   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cerebellar ataxia; Cerebellar inhibitory synapses; Glutamate decarboxylase; Presynaptic impairment

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CEREBELLAR ATAXIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTERNEURON; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT; STIFF MAN SYNDROME;

ACTION POTENTIALS; AGED; ANIMALS; AUTOANTIBODIES; BICUCULLINE; CALCIUM; CALCIUM-BINDING PROTEINS; CEREBELLAR ATAXIA; CEREBELLAR CORTEX; FEMALE; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOGLOBULIN G; NERVE TISSUE PROTEINS; NEURAL INHIBITION; PRESYNAPTIC TERMINALS; PURKINJE CELLS; RATS; STIFF-PERSON SYNDROME; SYNAPTIC TRANSMISSION;

EID: 0034175505     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00272-0     Document Type: Article

References (12)

1. Solimena M, DeCamilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 1991;14:452-7.
2. Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med 1996;2:148-53.
3. Honnorat J, Trouillas P, Thivolet C, Aguera M, Belin MF. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 1995;52:462-8.
4. Giometto B, Miotto D, Faresin F, Argentiero V, Scaravilli T, Tavolato B. Anti-GABAergic neuron autoantibodies in a patient with Stiff-man syndrome and ataxia. J Neurol Sci 1996;143:57-9.
5. Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997;49:1026-30.
6. Abele M, Weller M, Mescheriakov S, Bürk K, Dichgans J, Klockgether T. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 1999;52:857-9.
7. Ishida K, Mitoma H, Song S-Y, Uchihara T, Inaba A, Eguchi S, Kobayashi T, Mizusawa H. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 1999;46:263-7.
8. Yamakuni T, Usui H, Iwanaga T, Kondo H, Odani S, Takahashi Y. Isolation and immunohistochemical localization of a cerebellar protein. Neurosci Lett 1984;45:235-40.
9. O'Donovan MJ, Rinzel J. Synaptic depression: a dynamic regulator of synaptic communication with varied functional roles. Trends Neurosci 1997;20:431-3.
10. Mitoma H, Kobayashi T, Song SY, Konishi S. Enhancement by serotonin of GABA-mediated inhibitory synaptic currents in rat cerebellar Purkinje cells. Neurosci Lett 1994;173:127-30.
11. Mitoma H, Konishi S. Monoaminergic long-term facilitation of GABA-mediated inhibitory transmission at cerebellar synapses. Neuroscience 1999;88:871-83.
12. Dinkel K, Meinck H-M, Jury KM, Karges W, Richter W. Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998;44:194-201.